Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Generic User Fee Talks: Performance Metrics For Early Years Still Unresolved

Executive Summary

Industry and FDA appear largely in agreement on goals for the generic drug user fee program after it gets off the ground, but are stuck on how to determine agency performance in its early years.
Advertisement

Related Content

ANDA User Fee Negotiations Finished; Backlog To Be Mostly Cleared By Year Five
ANDA User Fee Negotiations Finished; Backlog To Be Mostly Cleared By Year Five
Generic Drug User Fees Will Begin With The Backlog
Generic Drug User Fees Will Begin With The Backlog
How "Clean" Will PDFUA V Be? Rep. Pitts Explains His Vacuuming Technique
Generic User Fees: API Manufacturers To Pay Less Than Finished Dose Firms
Generic User Fees: API Manufacturers To Pay Less Than Finished Dose Firms
Pre-NDA Work Takes Added Importance As PDUFA V Stretches Review Cycle
"Mega-UFA" Is Behind Schedule; Combined User Fee Bill Will Be Difficult, But Still Expected
FDA USER FEE LEGISLATION SET FOR SENATE LABOR & HUMAN RESOURCES HEARING ON SEPT. 22; Rx-TO-OTC SWITCH APPLICATION FEES ADDED TO BILL DURING HOUSE MARKUP

Topics

Advertisement
UsernamePublicRestriction

Register

PS053574

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel